Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors

S. I. Bearman, Motomi (Tomi) Mori, P. G. Beatty, W. G. Meyer, C. D. Buckner, F. B. Petersen, J. E. Sanders, C. Anasetti, P. Martin, F. R. Appelbaum, J. A. Hansen

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The nature and incidence of life-threatening or fatal toxicity after marrow transplantation were analyzed in 52 patients who received HLA-A, B, DR, Dw-phenotypically identical marrow transplants from unrelated volunteer donors (URD). An age and disease-matched cohort of 104 patients transplanted from HLA-genotypically identical siblings was used as a comparative group. The actuarial probability of grade 3 or 4 regimen-related toxicity was 31% after URD transplants and 21% after matched sibling transplants (log-rank p = 0.1041). The median duration of first hospitalization was 33 days for recipients of genotypically-identical marrow and 36 days for recipients of URD marrow (p = 0.0244). Sixty percent of genotypically identical marrow recipients and 51% of unrelated volunteer donor marrow recipients were discharged home from Seattle free of disease at a median of 99 days post-transplant (p = 0.5095). The percentage of patients requiring readmission to hospital and the actuarial probability of requiring either hemodialysis or mechanical ventilation were not statistically different between the two groups. We conclude that matched URD marrow transplantation is not associated with significantly greater regimen-related toxicity or mortality than transplantation from HLA-genotypical siblings.

Original languageEnglish (US)
Pages (from-to)31-35
Number of pages5
JournalBone Marrow Transplantation
Volume13
Issue number1
StatePublished - 1994
Externally publishedYes

Fingerprint

Unrelated Donors
Siblings
Transplantation
Bone Marrow
Morbidity
Volunteers
Mortality
Transplants
Patient Readmission
HLA-A Antigens
HLA-B Antigens
Artificial Respiration
Renal Dialysis
Hospitalization
Incidence

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors. / Bearman, S. I.; Mori, Motomi (Tomi); Beatty, P. G.; Meyer, W. G.; Buckner, C. D.; Petersen, F. B.; Sanders, J. E.; Anasetti, C.; Martin, P.; Appelbaum, F. R.; Hansen, J. A.

In: Bone Marrow Transplantation, Vol. 13, No. 1, 1994, p. 31-35.

Research output: Contribution to journalArticle

Bearman, SI, Mori, MT, Beatty, PG, Meyer, WG, Buckner, CD, Petersen, FB, Sanders, JE, Anasetti, C, Martin, P, Appelbaum, FR & Hansen, JA 1994, 'Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors', Bone Marrow Transplantation, vol. 13, no. 1, pp. 31-35.
Bearman, S. I. ; Mori, Motomi (Tomi) ; Beatty, P. G. ; Meyer, W. G. ; Buckner, C. D. ; Petersen, F. B. ; Sanders, J. E. ; Anasetti, C. ; Martin, P. ; Appelbaum, F. R. ; Hansen, J. A. / Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors. In: Bone Marrow Transplantation. 1994 ; Vol. 13, No. 1. pp. 31-35.
@article{f285ffee584a4e9bbd88bd467419f6b7,
title = "Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors",
abstract = "The nature and incidence of life-threatening or fatal toxicity after marrow transplantation were analyzed in 52 patients who received HLA-A, B, DR, Dw-phenotypically identical marrow transplants from unrelated volunteer donors (URD). An age and disease-matched cohort of 104 patients transplanted from HLA-genotypically identical siblings was used as a comparative group. The actuarial probability of grade 3 or 4 regimen-related toxicity was 31{\%} after URD transplants and 21{\%} after matched sibling transplants (log-rank p = 0.1041). The median duration of first hospitalization was 33 days for recipients of genotypically-identical marrow and 36 days for recipients of URD marrow (p = 0.0244). Sixty percent of genotypically identical marrow recipients and 51{\%} of unrelated volunteer donor marrow recipients were discharged home from Seattle free of disease at a median of 99 days post-transplant (p = 0.5095). The percentage of patients requiring readmission to hospital and the actuarial probability of requiring either hemodialysis or mechanical ventilation were not statistically different between the two groups. We conclude that matched URD marrow transplantation is not associated with significantly greater regimen-related toxicity or mortality than transplantation from HLA-genotypical siblings.",
author = "Bearman, {S. I.} and Mori, {Motomi (Tomi)} and Beatty, {P. G.} and Meyer, {W. G.} and Buckner, {C. D.} and Petersen, {F. B.} and Sanders, {J. E.} and C. Anasetti and P. Martin and Appelbaum, {F. R.} and Hansen, {J. A.}",
year = "1994",
language = "English (US)",
volume = "13",
pages = "31--35",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors

AU - Bearman, S. I.

AU - Mori, Motomi (Tomi)

AU - Beatty, P. G.

AU - Meyer, W. G.

AU - Buckner, C. D.

AU - Petersen, F. B.

AU - Sanders, J. E.

AU - Anasetti, C.

AU - Martin, P.

AU - Appelbaum, F. R.

AU - Hansen, J. A.

PY - 1994

Y1 - 1994

N2 - The nature and incidence of life-threatening or fatal toxicity after marrow transplantation were analyzed in 52 patients who received HLA-A, B, DR, Dw-phenotypically identical marrow transplants from unrelated volunteer donors (URD). An age and disease-matched cohort of 104 patients transplanted from HLA-genotypically identical siblings was used as a comparative group. The actuarial probability of grade 3 or 4 regimen-related toxicity was 31% after URD transplants and 21% after matched sibling transplants (log-rank p = 0.1041). The median duration of first hospitalization was 33 days for recipients of genotypically-identical marrow and 36 days for recipients of URD marrow (p = 0.0244). Sixty percent of genotypically identical marrow recipients and 51% of unrelated volunteer donor marrow recipients were discharged home from Seattle free of disease at a median of 99 days post-transplant (p = 0.5095). The percentage of patients requiring readmission to hospital and the actuarial probability of requiring either hemodialysis or mechanical ventilation were not statistically different between the two groups. We conclude that matched URD marrow transplantation is not associated with significantly greater regimen-related toxicity or mortality than transplantation from HLA-genotypical siblings.

AB - The nature and incidence of life-threatening or fatal toxicity after marrow transplantation were analyzed in 52 patients who received HLA-A, B, DR, Dw-phenotypically identical marrow transplants from unrelated volunteer donors (URD). An age and disease-matched cohort of 104 patients transplanted from HLA-genotypically identical siblings was used as a comparative group. The actuarial probability of grade 3 or 4 regimen-related toxicity was 31% after URD transplants and 21% after matched sibling transplants (log-rank p = 0.1041). The median duration of first hospitalization was 33 days for recipients of genotypically-identical marrow and 36 days for recipients of URD marrow (p = 0.0244). Sixty percent of genotypically identical marrow recipients and 51% of unrelated volunteer donor marrow recipients were discharged home from Seattle free of disease at a median of 99 days post-transplant (p = 0.5095). The percentage of patients requiring readmission to hospital and the actuarial probability of requiring either hemodialysis or mechanical ventilation were not statistically different between the two groups. We conclude that matched URD marrow transplantation is not associated with significantly greater regimen-related toxicity or mortality than transplantation from HLA-genotypical siblings.

UR - http://www.scopus.com/inward/record.url?scp=0028009203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028009203&partnerID=8YFLogxK

M3 - Article

C2 - 8019451

AN - SCOPUS:0028009203

VL - 13

SP - 31

EP - 35

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 1

ER -